Information and support for patients on endocrine therapy
Patients prescribed adjuvant endocrine therapy should be provided with information and support to continue their full course of therapy.
It is recommended that primary care clinicians should counsel patients to adhere to adjuvant endocrine (antiestrogen) therapy (Level of evidence 2A – NCCN guidelines)
How this guidance was developed
This recommendation was adapted from the ACS/ASCO 2016 guidelines (US). The source recommendation was based on a systematic review of the evidence conducted to April 2015 and was not graded by the source guideline authors. The source recommendation was accepted with minor stylistic changes, but with no changes to the meaning or tone of the source recommendation.
Information and support for patients on endocrine therapy
Patients prescribed adjuvant endocrine therapy should be provided with information and support to continue their full course of therapy.
This recommendation was adapted from the ACS/ASCO 2016 guidelines (US). The source recommendation was based on a systematic review of the evidence conducted to April 2015 and was not graded by the source guideline authors. The source recommendation was accepted with minor stylistic changes, but with no changes to the meaning or tone of the source recommendation.